product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-p90RSK (Thr359) (D1E9) Rabbit mAb
catalog :
8753
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
D1E9
reactivity :
human, dog
application :
western blot, immunocytochemistry
more info or order :
Cell Signaling Technology product webpage
citations: 2
Published Application/Species/Sample/DilutionReference
  • western blot; human; 1:1000; loading ...; fig 1e
Gross S, Rotwein P. Quantification of growth factor signaling and pathway cross talk by live-cell imaging. Am J Physiol Cell Physiol. 2017;312:C328-C340 pubmed publisher
  • western blot; human; fig 1c
Vakana E, Pratt S, Blosser W, Dowless M, Simpson N, Yuan X, et al. LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer. Oncotarget. 2017;8:9251-9266 pubmed publisher
product information
SKU :
8753S
Product-Name :
Phospho-p90RSK (Thr359) (D1E9) Rabbit mAb
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H, Mk, (C, X, Dg, Hr)
Applications :
Immunofluorescence (Immunocytochemistry)
Product-Category :
MAP Kinase Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
90
Host :
Rabbit
Target :
RSK1 (Thr359/Ser363) phosphate
Primary-Protein :
p90RSK
Alt-Names :
90 kDa ribosomal protein S6 kinase 1,HU-1,KS6A1,MAP kinase-activated protein kinase 1a,MAPK-activated protein kinase 1a,MAPKAP kinase 1a,MAPKAPK-1a,MAPKAPK1A,RPS6KA1,RSK,RSK-1,RSK1,Ribosomal S6 kinase 1,Ribosomal protein S6 kinase alpha-1,S6K-alpha 1,S6K-alpha-1,dJ590P13.1 (ribosomal protein S6 kinase, 90kD, polypeptide 1),p90-RSK 1,p90RSK1,p90S6K,ribosomal protein S6 kinase alpha 1,ribosomal protein S6 kinase, 90kDa, polypeptide 1
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.